Molecular profiling
Testing can examine molecular changes or biomarkers in a cancer. The scope and interpretation depend on the specific test and the clinical context.
Molecular diagnosticsMolecular diagnostics.
Molecular diagnostics.
Information for informed discussions.
Explore cancer NGS and molecular profiling, and the questions to consider when discussing testing with a clinical team. Contact AceProbe for general service enquiries.
Cancer NGS & molecular profiling
Understanding the role of molecular information.
Targeted-therapy discussions
Biomarker findings may help inform treatment discussions. Clinical interpretation and treatment decisions belong with the treating oncologist.
A test-specific approach
Review the test’s intended use, laboratory, sample requirements, reporting scope and limitations with the responsible provider.
Biomarker testing does not guarantee a suitable targeted therapy or a treatment benefit. Read the National Cancer Institute overview. Testing and treatment decisions should be discussed with the treating oncologist.
Questions to discuss
Clarity before a test is arranged.
Test scopeWhat the test examines, its intended use and important limitations
Responsible laboratoryWho performs and interprets the test, and the relevant scope of laboratory credentials
Requirements & logisticsProvider-approved sample guidance, handling, transport and reporting timelines
Reporting & follow-upHow results are explained and discussed with the treating clinical team
General service enquiriesAsk about the service.
Ask about the service.
Keep patient information private.
Contact our team with general questions about molecular diagnostics and the information you need from a service provider.
Do not submit patient names or identifiers, medical reports, test results, diagnoses or other health information. This enquiry form is not for clinical advice or case review.
Make a general service enquiry